Forum starts in

5.2. Promoting Competition and Innovation Through Access to Non-voluntary Licensing: the Pharmaceutical Industry Experience

Track: 5. Antimonopoly Regulation


The Discussion Session is organized by "SIA INTERNATIONAL Ltd"

Providing open access to scientific developments and using various forms of compulsory licensing have become one of the key tools for stimulating innovation and development in developed economies. For example, the declaration of the Max Planck Institute (Germany), signed by 40 distinguished legal scholars from 25 countries, dedicated to the 20th anniversary of the adoption of the TRIPS Agreement expressly states, in particular, that "compulsory licensing ensures the efficiency of innovation markets by reducing the risks of using patents as barriers to invention and innovation".

In its recent report “Promoting Innovation and Access to Health Technologies”, the UN High-Level Panel on Access to Medicines is also concluding that the WTO Members must make full use of TRIPS flexibilities as reaffirmed by the Doha Declaration on TRIPS and Public Health and also must demand free and wide access to knowledge obtained as a result of scientific research created at the state expense.

How to use such instruments as non-voluntary licensing and access to knowledge to address the developmental needs in the pharmaceutical sector both in the competition law and intellectual property law contexts? What are the best practices to follow? The session will examine the Russian and other international experiences in the use of various tools and methods of non-voluntary licensing and will evaluate their effectiveness, from a legal and economic perspective, in view of the need to promote innovation.


Timophey Nizhegorodtsev

Head of the Department for Control over Social Sphere and Trade, Federal Antimonopoly Service of the Russian Federation


Denis Afanasov


Igor Artemiev

Head, Federal Antimonopoly Service of the Russian Federation

Maria Borzova

Project Manager of Pharmaceutical Direction, VEGAS LEX

William Comanor

Professor, University of California

Alexey Ivanov

Director, HSE-Skolkovo Institute for Law and Development

Maria Kobanenko

Adviser, Egorov, Puginskyi, Afanasiev & Partners

Liubov Kiriy

Deputy Director General, Federal Service for Intellectual Property

Björn Lundqvist

Professor, Stockholm University

Jerome Reichman

Professor, Duke University

Igor Ryzhkov

Head of the Intellectual Property Rights Protection Division, Pharmasynthez

Theodor Thanner

Head, Austrian Competition Authority

*This schedule may be subject to change